400
Participants
Start Date
December 2, 2025
Primary Completion Date
December 2, 2026
Study Completion Date
December 2, 2029
No intervention: observational study
No intervention: observational study
Gulbenkian Institute for Molecular Medicine, Lisbon
Fundacao Champalimaud
OTHER
Centro Hospitalar Lisboa Norte
OTHER
Gulbenkian Institute for Molecular Medicine
OTHER